Gene Query: SSH1

Dataset Description Geneva Score
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 65.94
Knockdown of ADNP in HCT116 colon cancer cells 51.26
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 48.6
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 45.54
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 38.87
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 37.35
Region-specific Innate Antiviral Responses of the Human Epididymis 37.18
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 36.95
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 35.72
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 35.56
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 35.4
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 33.23
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 32.68
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 31.76
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 31.76
RNAseq Analysis in glioblastoma cells treated with Mepazine 31.62
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 29.81
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 29.15
Gene Expression Profiling of SPOP Knocked Down Cell 28.91
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 28.38
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 27.15
Gene expression changes upon drug withdrawal (Mel888 cell line) 25.75
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 25.74
CD95/Fas ligand mRNA is toxic to cells 25.64
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 25.16
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 25.05
Differential expression of genes in AD169-infected MRC5. 25.02
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 24.03
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 23.17
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 22.62
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 21.94
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 21.44
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 21.38
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 20.63
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation 20.61
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 20.5
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 20.29
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 20.29
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 20.29
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 20.13
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 20.07
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 19.57
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 19.51
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 19.43
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 19.43
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 19.4
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 19.4
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 19.38
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 19.2
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 19.2
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 19.06
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 18.99
BAF controls genome accessibility 18.46
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 18.41
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 18.41
RNA-seq in HepG2 and IMR90 cells 18.07
Evolution of a transcriptional regulator from a transmembrane nucleoporin 18.07
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 18.0
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 17.88
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 17.84
miRNAs affected by antagomiR-17 treatment 17.67
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 17.62
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 17.55
TFAP2C signalling in human fibroblasts 17.55
circRNA-sequencing 17.54
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 17.45
RNA sequencing of GlyH-101-treated MCF-7 cell line 17.39
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 17.13
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 16.77
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 16.66
RNA sequencing of mechanically strained NHEKs and control NHEKs 16.65
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 16.58
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 16.36
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 16.36
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 16.3
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 16.25
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 16.25
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 16.19
MicroRNA targetome analysis during HCMV infection 16.18
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 16.17
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 15.95
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 15.87
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 15.85
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 15.78
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 15.69
Genetic-to-epigenetic Therapy for Pancreatic Cancer 15.63
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 15.6
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 15.48
ARID1A and ARID1B loss in HCT116 cells 15.4
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 15.23
The pioneer factor CEBPA modulates vitamin D signaling 15.23
Modeling Familial Cancer with iPSC Approaches 15.19
ZIKV infection of monocytes activates inflammasome pathways 14.95
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 14.91
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 14.85
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 14.85
The interplay between SOX4 and SMAD3 in the context of breast cancer 14.75
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 14.74
SLAM-seq for K562 endogenous mRNA decay 14.72
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 14.57
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 14.57
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 14.57
Rorc disruption in human FG pancreatic cancer cells 14.46
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 14.38
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 14.37
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 14.32
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 14.32
14.27
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 14.14
Regulation of highly expressed hCINAP on translatome 14.02
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 13.95
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 13.84
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 13.84
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 13.79
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 13.77
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 13.52
Lysine benzoylation is a novel histone mark [RNA-seq] 13.37
Lysine benzoylation is a novel histone mark 13.37
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 13.28
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 13.08
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 13.08
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 13.05
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 12.91
Effects of rFVIIIFc on human macrophages 12.87
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 12.84
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 12.62
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 12.59
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 12.55
RNA-seq of MCF10A cells and CAF 12.53
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 12.52
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 12.43
Transcriptome analysis of kidney organoids 12.37
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 12.34
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 12.33
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 12.32
Tracing Enhancer Networks using Epigenetic Traits (TENET) 12.32
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 12.3
LncRNA expression profiling of ischemic stroke patients 12.26
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 12.21
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 12.2
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 12.2
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 12.18
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 12.14
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 12.04
Selective suppression of endothelial cytokine production by progesterone receptor 11.98
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 11.98
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 11.98
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 11.98
RNA-sequencing in irradiated and normal A549 cells. 11.96
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 11.91
Lipid Nanoparticle-Mediated Delivery of Anti-miR-17 Family Oligonucleotide Suppresses Hepatocellular Carcinoma Growth 11.85
mRNA Profiling of miR-17 family inhibition using TuD lentiviral vector in HepG2 and SK-Hep1 hepatocellular carcinoma cell lines [RNA-Seq] 11.85
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 11.83
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 11.83
DJ-1 is dispensable for human stem cell homeostasis 11.78
Functional role of SLIT2 and ROBO1 in trophoblasts 11.76
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 11.68
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 11.67
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 11.64
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 11.48
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 11.48
RNA deep sequencing analysis of human brain microvascular endothelial cells (ECs) treated with glioma-conditioned medium (glioma-CM) 11.42
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 11.41
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 11.41
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 11.4
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 11.27
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 11.1
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 11.1
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 11.1
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 10.9
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 10.9
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 10.86
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 10.85
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 10.83
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 10.81
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 10.77
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 10.71
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 10.71
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 10.66
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 10.64
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 10.63
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 10.63
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 10.57
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 10.55
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 10.55
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 10.54
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 10.53
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 10.48
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 10.46
Capturing the Interactome of Newly Transcribed RNA 10.46
Capturing the Interactome of Newly Transcribed RNA (RICK) 10.46
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 10.4
Transcriptome profiling of Normal and Cancerous Prostate Cells 10.4
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 10.4
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 10.37
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 10.37
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 10.31
Regulation of protein translation during mitosis 10.27
STRIPAK directs PP2A activity to promote oncogenic transformation 10.26
Effect of Hotair overexpression in human breast cancer cell lines 10.22
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 10.15
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 10.15
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 10.12
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 10.11
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 10.08
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 10.03
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 9.94
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 9.9
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 9.9
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 9.8
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 9.77
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 9.76
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 9.74
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 9.73
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 9.7
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 9.66
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 9.62
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 9.6
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 9.6
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 9.6
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 9.6
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 9.59
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 9.59
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells 9.57
LIN28A modulates splicing and gene expression programs in breast cancer cells 9.53
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 9.53
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 9.52
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 9.44
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 9.44
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 9.44
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 9.38
High-efficiency RNA-based reprogramming of human primary fibroblasts 9.37
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 9.36
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 9.36
Proliferation-correlated expression 9.35
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 9.34
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 9.31
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 9.3
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 9.28
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 9.27
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 9.13
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 9.12
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 9.09
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 9.06
TCF7L1 knockdown in pancreatic cancer 9.05
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 9.01
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 8.92
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 8.91
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 8.91
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 8.91
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 8.91
Cell responses to dysregulated VZV-induced cell-cell fusion 8.88
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 8.85
Expression profiling of etoposide-induced senescent cells 8.81
Ribosomal footprinting of MDA-Parental and MDA-LM2 8.81
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 8.79
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 8.61
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 8.56
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 8.54
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 8.45
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 8.45
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 8.44
Illumina Total RNA-seq in HeLa 8.43
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 8.41
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 8.4
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 8.37
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 8.34
BCL11B 8.33
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 8.3
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 8.29
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 8.24
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 8.2
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 8.19
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 8.16
Differential gene expression profiles in imatinib-resistant cell lines 8.13
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 8.08
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 8.08
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 8.06
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 8.03
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 7.96
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 7.96
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 7.9
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 7.9
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 7.86
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 7.86
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 7.82
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 7.82
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 7.78
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 7.75
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 7.71
Characterization of human ILC2 subsets 7.69
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 7.67
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 7.66
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 7.66
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 7.63
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 7.6
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 7.59
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 7.59
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 7.58
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 7.56
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 7.54
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 7.46
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 7.39
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 7.36
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 7.34
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 7.28
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 7.28
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 7.24
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 7.21
Selective expression of long non-coding RNAs in a breast cancer cell progression model 7.19
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 7.17
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 7.17
Searching for target genes of miR-508/509/506/514 in HCT116 cells 7.1
RNA sequencing of human mammary epithelial cells 7.05
A single-cell transcriptome atlas of the human pancreas 7.04
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 7.04
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 7.04
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 7.02
SLIGRL-induced gene expression changes in NHEK cells 6.98
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 6.96
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 6.88
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 6.84
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 6.81
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 6.75
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 6.74
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 6.73
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 6.71
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 6.69
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 6.6
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 6.2
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 6.19
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 6.05
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 6.05
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 6.04
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 6.04
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 5.97
The cytokine environment influence on human skin-derived T cells 5.96
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 5.9
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 5.9
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 5.88
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 5.87
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 5.78
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 5.78
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 5.66
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 5.61
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 5.54
Transcriptomes of oxLDL exposed trained monocytes 5.46
oxLDL exposed trained monocytes 5.46
Mapping interactions for the TNIP2 hub protein 5.45
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.43
mRNA expression profile of Lymphocytes by high-throuput sequencing 5.32
Tpl-2 small molecule project 5.32
Tpl-2 and MEK small molecule inhibitors 5.32
4sUDRB-seq: measuring transcription elongation and initiation genomewide 5.29
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 5.16
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 5.16
Conservative alteration of chromosomal expression pattern across human solid tumor types 5.08
Dermal endothelial cells of type 2 diabetic patients 5.08
Effect of drugs on transcriptomic profiles 5.03
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 4.98
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 4.98
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 4.97
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 4.82
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 4.81
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 4.76
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 4.76
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 4.75
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 4.68
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.66
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 4.56
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 4.5
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 4.5
Small-molecule targeting of brachyury transcription factor addiction in chordoma 4.48
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 4.42
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 4.42
A map of gene expression in neutrophil-like cell lines 4.4
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 4.4
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 4.32
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 4.27
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 4.26
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 4.22
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 4.17
Effect of PBK knockdown on C4-2 cell transcriptome 4.16
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 4.1
HEK293 Heat-shock experiment 4.1
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 4.08
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  4.04
Toxoplasma gondii infection of human retinal pigment epithelial cells 3.99
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 3.94
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 3.94
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 3.89
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 3.89
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 3.88
6mer seed toxicity in viral microRNAs 3.86
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 3.76
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 3.76
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 3.76
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 3.75
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 3.6
Copper Regulation of HIF-1 Transcription Activity 3.58
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.58
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.55
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 3.54
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 3.51
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 3.49
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 3.48
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 3.47
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.42
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 3.42
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 3.37
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 3.37
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.34
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 3.3
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 3.18
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 3.09
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 3.08
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 3.08
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 3.05
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.02
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.02
Human Tfh cell RNA bulk sequencing 3.01
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 2.98
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 2.89
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 2.89
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.88
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.88
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 2.82
HEXIM1 is induced by DHODH inhibition to suppress melanoma 2.82
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.76
Identification of Sin3B regulated genes during quiescence 2.74
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 2.73
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 2.71
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 2.64
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 2.61
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 2.56
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 2.52
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 2.51
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.5
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 2.36
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 2.32
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 2.29
Human ovarian granulosa cell transcriptome 2.25
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 2.25
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 2.17
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.16
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 2.07
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 2.04
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 2.02
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 1.98
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 1.93
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 1.89
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.86
ARID1A and ARID1B loss in HCT116 and TOV21G cells 1.85
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 1.82
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 1.74
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 1.74
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 1.68
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 1.68
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 1.57
EGR1-controlled transcriptome of T HESCs 1.55
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.53
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 1.4
Metabolism as an early predictor of DPSCs aging 1.34
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 1.34
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.31
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.25
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.23
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.23
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.05
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 1.03
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.96
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.88
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 0.8
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.76
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.75
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.75
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 0.71
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.71
The role of m6A/m-RNA methylation in stress response regulation 0.71
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.68
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.6
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 0.58
Ribosome profiling upon inhibition of eIF4A 0.58
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 0.55
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.55
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.51
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.47
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.43
A code of mono-phosphorylation modulates the function of RB. 0.4
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.38
RNA-seq of CD33 KO and control HSPCs 0.27
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 0.25
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.21
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.19
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 0.18
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 0.18
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.1
Aortic Valve Tissue: Stenosis vs. Sclerosis 0.06
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 0.03
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation